MD
Maria Durairaj Gnanaprakash
About Maria Durairaj Gnanaprakash
Data last updated:
Maria Durairaj Gnanaprakash is a Director at Sygra Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Sygra Pharmaceutical Private Limited reported revenue of ₹87,537 (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sygra Pharmaceutical Private Limited U46497TN2023PTC165673 | Director | 30 Nov 2023 | 2023 | ₹87,537 (FY 2024) | Active |
Board colleagues of Maria Durairaj Gnanaprakash
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manoharan Saral Mano Ranjitham | 10411248 | Sygra Pharmaceutical Private Limited | Director |
| Rathipriya K | 10411249 | Sygra Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maria Durairaj Gnanaprakash
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maria Durairaj Gnanaprakash
Maria Durairaj Gnanaprakash currently holds 1 directorship: Sygra Pharmaceutical Private Limited (Director, since 30 Nov 2023, revenue ₹87,537 (FY 2024)).
Maria Durairaj Gnanaprakash was first appointed on 30 Nov 2023 as Director at Sygra Pharmaceutical Private Limited.
The current boards of Maria Durairaj Gnanaprakash's companies include Manoharan Saral Mano Ranjitham (Sygra Pharmaceutical Private Limited), Rathipriya K (Sygra Pharmaceutical Private Limited).